LiqTech International - LIQT Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LiqTech International in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" LIQT shares.
View LIQT analyst ratings or view top-rated stocks.

2 equities research analysts have issued 12 month price objectives for LiqTech International's stock. Their LIQT share price forecasts range from $3.00 to $3.00. On average, they expect the company's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 431.5% from the stock's current price.
View analysts price targets for LIQT or view top-rated stocks among Wall Street analysts.

LiqTech International's stock was trading at $0.38 at the start of the year. Since then, LIQT shares have increased by 48.5% and is now trading at $0.5644.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our LIQT earnings forecast.

LiqTech International, Inc. (NASDAQ:LIQT) issued its quarterly earnings data on Thursday, November, 10th. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $3.31 million for the quarter. LiqTech International had a negative net margin of 81.16% and a negative trailing twelve-month return on equity of 71.61%.

Shares of LiqTech International reverse split before market open on Tuesday, April 16th 2019. The 1-4 reverse split was announced on Thursday, March 28th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 15th 2019. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other LiqTech International investors own include Gilead Sciences (GILD), Bank of America (BAC), Digital Turbine (APPS), Zynga (ZNGA), YANGAROO (YOO), Vera Bradley (VRA), United States Oil Fund (USO), Syndax Pharmaceuticals (SNDX), Protalix BioTherapeutics (PLX) and NeoGenomics (NEO).

LiqTech International trades on the NASDAQ under the ticker symbol "LIQT."

LiqTech International's stock is owned by a variety of retail and institutional investors. Top institutional investors include WealthTrust Axiom LLC (1.62%), Clear Harbor Asset Management LLC (1.32%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Alexander J Buehler, Laurence W Lytton, Peyton Boswell and Simon Seidelin Stadil.
View institutional ownership trends.

Shares of LIQT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LIQT stock can currently be purchased for approximately $0.56.

LiqTech International (NASDAQ:LIQT) has a market capitalization of $24.78 million and generates $18.27 million in revenue each year. The company earns $-11,130,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

The company employs 112 workers across the globe.

LiqTech International's mailing address is Industriparken 22C DK 2750, Ballerup G7, DK 2750. The official website for the company is www.liqtech.com. The company can be reached via phone at (454) 498-6000, via email at info@liqtech.com, or via fax at 45-4498-6061.